Voyager Therapeutics, Inc.
MX ˙ BMV ˙ US92915B1061
SecurityMX:VYGR / Voyager Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership3,869 shares
Latest Disclosed Value $ 14,934
Citigroup Inc reports 43.35% increase in ownership of VYGR / Voyager Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 3,869 shares of Voyager Therapeutics, Inc. (MX:VYGR) valued at $14,934 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,699 shares of Voyager Therapeutics, Inc.. This represents a change in shares of 43.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 3,869 1,170 43.35 15 40.00 0.0000
2026-02-13 2025-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 2,699 -2,634 -49.39 11 -58.33 0.0000
2025-11-10 2025-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 5,333 -18,168 -77.31 25 -67.12 0.0000
2025-08-11 2025-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 23,501 -9,460 -28.70 73 -34.23 0.0000
2025-05-12 2025-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 32,961 -6,517 -16.51 111 -50.22 0.0001
2025-02-12 2024-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 39,478 2,500 6.76 224 3.24 0.0001
2024-11-12 2024-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 36,978 16,658 81.98 216 35.00 0.0001
2024-08-12 2024-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 20,320 -85,273 -80.76 161 -83.72 0.0001
2024-05-10 2024-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 105,593 100,230 1,868.92 983 2,084.44 0.0006
2024-02-09 2023-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 5,363 5,346 31,447.06 45 0.0000
2023-12-06 2023-09-30 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 17 -9,525 -99.82 0 -100.00 0.0000
2023-11-09 2023-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 17 -9,525 0 0.0000
2023-08-10 2023-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 9,542 -76,090 -88.86 109 -83.48 0.0001
2023-05-11 2023-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 85,632 1,599 1.90 660 28.91 0.0005
2023-02-09 2022-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 84,033 80,749 2,458.86 513 2,594.74 0.0004
2022-11-10 2022-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 3,284 3,284 19 0.0000
2022-08-10 2022-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 0 -24,461 -100.00 0 -100.00
2022-05-12 2022-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 24,461 24,461 186 0.0001
2022-02-10 2021-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 0 -1,988 -100.00 0 -100.00
2021-11-10 2021-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,988 -299 -13.07 5 -44.44 0.0000
2021-08-10 2021-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 2,287 -396 -14.76 9 -25.00 0.0000
2021-05-13 2021-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 2,683 -14,150 -84.06 12 -90.00 0.0000
2021-02-11 2020-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 16,833 7,478 79.94 120 21.21 0.0001
2020-11-12 2020-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 9,355 -15,199 -61.90 99 -68.06 0.0001
2020-08-12 2020-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 24,554 -7,055 -22.32 310 7.27 0.0002
2020-05-12 2020-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 31,609 10,259 48.05 289 -3.02 0.0003
2020-02-12 2019-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 21,350 -52,345 -71.03 298 -76.52 0.0002
2019-11-08 2019-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 73,695 -8,341 -10.17 1,269 -43.17 0.0010
2019-08-12 2019-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 82,036 45,115 122.19 2,233 216.29 0.0018
2019-05-13 2019-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 36,921 -84,178 -69.51 706 -37.96 0.0007
2019-02-12 2018-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 121,099 56,050 86.17 1,138 -7.55 0.0012
2018-11-13 2018-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 65,049 20,538 46.14 1,231 41.49 0.0011
2018-08-10 2018-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 44,511 8,845 24.80 870 29.85 0.0008
2018-05-11 2018-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 35,666 24,144 209.55 670 250.79 0.0006
2018-02-12 2017-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 11,522 11,522 191 0.0002
2017-11-13 2017-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 0 -97 -100.00 0 -100.00
2017-08-11 2017-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 97 72 288.00 1 0.0000
2017-05-12 2017-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 25 -1,785 -98.62 0 -100.00
2017-02-10 2016-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,810 1,810 23 0.0000
2016-11-10 2016-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 0 -1,174 -100.00 0 -100.00
2016-08-12 2016-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,174 -3,510 -74.94 13 -68.29 0.0000
2016-05-13 2016-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 4,684 2,948 169.82 41 7.89 0.0000
2016-02-12 2015-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,736 1,736 38 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.